Drug Type Shared antigen vaccine, DNA vaccine, Therapeutic vaccine |
Synonyms ME-103, ME-103.1.1, PX 103.1 + [3] |
Target |
Mechanism HER2 antagonists(Receptor protein-tyrosine kinase erbB-2 antagonists), Immunostimulants |
Therapeutic Areas |
Active Indication- |
Inactive Indication |
Originator Organization |
Active Organization- |
Inactive Organization |
Drug Highest PhaseDiscontinuedPhase 2 |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Breast Cancer | Phase 2 | DK | - | - |
Breast Cancer | Phase 2 | GB | - | - |
Breast Cancer | Phase 2 | - | - |